Quick Takeaways
- Natalie McAndrew has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- No recent insider transactions are currently listed.
Follow Filing Activity
Follow Natalie McAndrew and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BXRX | Baudax Bio, Inc. | Interim CFO | 09 Oct 2023 | |||
| CARM | Carisma Therapeutics Inc. | Vice President of Finance | 01 Jan 2025 |